Lipocine

#药闻简讯# $Lipocine(LPCN)$ 报告 LPCN 1154 在产后抑郁症患者中的安全性和有效性初步结果。
在接受治疗的 90 名 PPD 患者中，3 期研究人群的 HAM-D17 总评分与安慰剂相比，未显示出统计学意义上的显著降低。#临床研究失败#

#药闻简讯# $Lipocine(LPCN)$ 完成 LPCN 1154 产后抑郁症（PPD）III 期临床试验的入组与给药
Q2 初公布主要数据

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001641172-25-018333  Act: 34  Size: 41 MB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001641172-25-009772  Act: 34  Size: 52 MB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001641172-25-010118  Act: 34  Size: 249 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001641172-25-016589  Act: 34  Size: 243 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-015081  Act: 34  Size: 12 MB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-012698  Act: 34  Size: 15 MB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001641172-25-009179  Act: 34  Size: 313 KB 网页链接

$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-013795  Size: 5 KB 网页链接

$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-013794  Size: 5 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001493152-26-007287  Act: 34  Size: 252 KB 网页链接

$Lipocine(LPCN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0002050709-26-000004  Act: 34  Size: 80 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-008852  Act: 34  Size: 278 KB 网页链接

$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-26-014959  Size: 4 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-012740  Act: 34  Size: 239 KB 网页链接

$Lipocine(LPCN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-027914  Act: 34  Size: 244 KB 网页链接

$Lipocine(LPCN)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002050709-25-000012  Act: 34  Size: 80 KB 网页链接

$Lipocine(LPCN)$ Squadron Capital Management, LLC及其关联方Squadron Master Fund LP、Matthew Sesterhenn和William Blank已提交了13G表格，详细说明了他们对Lipocine Inc.普通股的实际所有权情况。作为投资顾问，Squadron Capital Management, LLC可能被视为基金持有股份的实际所有人。Matthew...

$Lipocine(LPCN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641172-25-013796  Size: 5 KB 网页链接